Table 1.
Differences in clinical parameters between patients with and without target organ damage (TOD)
| Parameter | With TOD (N = 92) | Without TOD (N = 86) | P value |
|---|---|---|---|
| Age, y | 63.0 ± 10.0 | 52.5 ± 11.5 | <.001 |
| Gender, % women | 41.3 | 23.3 | .010 |
| BMI, kg/m2 | 29.9 ± 4.6 | 28.8 ± 4.5 | .224 |
| Smokers, % | 23.9 | 24.4 | .937 |
| Diabetes, % | 26.1 | 16.3 | .018 |
| Dyslipidemia, % | 71.7 | 54.7 | .111 |
| Previous cardiovasculara event, % | 29.3 | 16.3 | .039 |
| Antihypertensive treatment, % | 96.7 | 86.0 | .014 |
| 24‐ h brachial SBP, mm Hg | 133.8 ± 14.5 | 124.5 ± 11.0 | <.001 |
| 24‐ h brachial DBP, mm Hg | 80.2 ± 9.5 | 79.9 ± 7.4 | .809 |
| 24‐ h aortic SBP, mm Hg | 122.8 ± 15.0 | 115.5 ± 10.2 | <.001 |
| 24‐ h aortic DBP, mm Hg | 81.9 ± 9.8 | 81.2 ± 7.6 | .615 |
| Daytime brachial SBP, mm Hg | 136.9 ± 15.1 | 128.9 ± 12.1 | <.001 |
| Daytime brachial DBP, mm Hg | 83.5 ± 10.3 | 84.0 ± 8.2 | .726 |
| Daytime aortic SBP, mm Hg | 125.9 ± 14.8 | 118.9 ± 10.6 | <.001 |
| Daytime aortic DBP, mm Hg | 85.5 ± 10.6 | 85.6 ± 8.5 | .918 |
| Night brachial SBP, mm Hg | 126.8 ± 17.3 | 115.7 ± 12.4 | <.001 |
| Night brachial DBP, mm Hg | 73.8 ± 9.9 | 71.3 ± 8.8 | .057 |
| Night aortic SBP, mm Hg | 17.3 ± 18.8 | 108.3 ± 12.4 | <.001 |
| Night aortic DBP, mm Hg | 74.8 ± 10.3 | 72.3 ± 9.0 | .055 |
| eGFR, mL/min/1.73 m2 | 73.7 ± 20.5 | 90.6 ± 15.0 | <.001 |
| Urinary albumin excretion, mg/g | 13 [4.9‐112] | 4.8 [2.5‐9.4] | <.001 |
| LVMI, g/m2 | 116.8 ± 27.7 | 84.7 ± 16.4 | <.001 |
| 24‐h aPWV, m/s | 9.3 ± 1.6 | 7.6 ± 1.2 | <.001 |
aPWV, aortic pulse wave velocity; BMI, body mass index; DBP, diastolic BP; eGFR, estimated glomerular filtration rate; LVMI, left ventricular mass index; SBP, systolic BP.
Means cardiac or cerebrovascular event.